Details for New Drug Application (NDA): 214594
✉ Email this page to a colleague
The generic ingredient in ETHINYL ESTRADIOL AND NORELGESTROMIN is ethinyl estradiol; norelgestromin. There are twenty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norelgestromin profile page.
Summary for 214594
Tradename: | ETHINYL ESTRADIOL AND NORELGESTROMIN |
Applicant: | Zydus Noveltech Inc |
Ingredient: | ethinyl estradiol; norelgestromin |
Patents: | 0 |
Pharmacology for NDA: 214594
Mechanism of Action | Estrogen Receptor Agonists |
Suppliers and Packaging for NDA: 214594
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ETHINYL ESTRADIOL AND NORELGESTROMIN | ethinyl estradiol; norelgestromin | FILM, EXTENDED RELEASE;TRANSDERMAL | 214594 | ANDA | Zydus Pharmaceuticals USA Inc. | 70710-1190 | 70710-1190-3 | 3 POUCH in 1 CARTON (70710-1190-3) / 1 POUCH in 1 POUCH (70710-1190-1) / 7 mg in 1 POUCH |
ETHINYL ESTRADIOL AND NORELGESTROMIN | ethinyl estradiol; norelgestromin | FILM, EXTENDED RELEASE;TRANSDERMAL | 214594 | ANDA | Zydus Lifesciences Limited | 70771-1777 | 70771-1777-3 | 3 POUCH in 1 CARTON (70771-1777-3) / 1 POUCH in 1 POUCH (70771-1777-1) / 7 mg in 1 POUCH |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FILM, EXTENDED RELEASE;TRANSDERMAL | Strength | 0.035MG/24HR;0.15MG/24HR | ||||
Approval Date: | Sep 14, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription